Collaboration is the engine of scientific progress at UW Medicine and at the Institute of Stem Cell & Regenerative Medicine (ISCRM), where 130 researchers are developing stem cell-based approaches to treat diseases affecting nearly every organ and system in the human body. Read More
Drug treatments can save lives, but sometimes they also carry unintended costs. After all, the same therapeutics that target pathogens and tumors can also harm healthy cells. To reduce this collateral damage, scientists have long sought specificity in drug delivery systems: A package that can encase a therapeutic and will not disgorge its toxic cargo until it reaches the site of treatment — be it a tumor, a diseased organ or a site of infection. Read More
Researchers are reporting significant progress in generating a 3-dimensional network of blood vessels that can be grown and manipulated in a laboratory. Building vascular support for stem-cell repaired tissues or replacement organs will be vital to such regenerative therapies. Read More
ISCRM is pleased to share that Dr. Cole DeForest will receive a Distinguished Teaching Award and Dr. Norm Beauchamp will receive the David B. Thorud Leadership Award at the 46th Annual Awards of […] Read More